Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Feb 20, 2019 (8 years ago)

Topical Solution USP Hydrogen Peroxide First Aid Antiseptic Oral…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Cross Contamination: Presence of IPA in finished product.

Cause type: Cross-contamination

Traces of another drug - most often penicillin - got into the product from shared equipment or facilities. Even trace penicillin can trigger a severe allergic reaction in someone who was never meant to receive it. All cross-contamination recalls.

What was recalled

Topical Solution USP Hydrogen Peroxide First Aid Antiseptic Oral Debriding Agent 32 Fl. Oz. (1 QT) 946 mL bottle, Distributed By: Discount Drug Mart 211 Commerce Drive, Medina, Ohio 44256 NDC 53943-871-45 UPC 0-93351-12758-8

Affected NDC 53943-0871-45

Compare with the code on your package — it is the most precise check available.

Recalling firm
Vi-Jon, Inc.
NDC code
53943-871-45
Origin
TN, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0520-2019 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Vi-Jon, Inc.

All 2019 recalls

Other cross-contamination recalls from 2019

All cross-contamination recalls
Class I · High risk

Lamotrigine Tablets

Cross Contamination; Lamotrigine Tablets 100 mg USP was contaminated with enalapril maleate.

Terminated Cross-contamination Taro Pharmaceuticals U.S.A., Inc. NDC 51672-4131-1 D-0833-2020
Class II · Moderate risk

Petroleum jelly

Cross contamination with other products: undeclared contaminants of phenol and camphor in petroleum jelly tubes.

Terminated Cross-contamination OraLabs, Incorporated D-0624-2020
Class II · Moderate risk

Temozolomide Capsules

CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.

Terminated Cross-contamination Deva Holding AS - Cerkezkoy Subesi NDC 67877-542-07 D-1513-2019
Class II · Moderate risk

Temozolomide Capsules

CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.

Terminated Cross-contamination Deva Holding AS - Cerkezkoy Subesi NDC 67877-541-07 D-1512-2019